Equitable Access to Multiple Myeloma Treatments Can Help Close the Survival Gap
Jennifer Flowers thought her pain and fatigue were a side effect of working out. Perhaps she'd pushed herself too hard or strained a muscle. But the pain persisted, so she scheduled an appointment with her doctor. Her diagnosis—multiple myeloma, a type of blood cancer—was unexpected.
Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
To better align with disease burden and unmet patient needs, Pfizer will now expand its offering under the Accord to include off-patent products, bringing the total offering from 23 products to around 500 products.